DNA Payments iwoca integration lets UK merchants apply for a Flexi Loan of between £1,000 and £1 million without leaving the Merchant Portal or app. The application is fully digital, and approvals typically come back within minutes.

Inside the DNA Payments iwoca deal

The DNA Payments iwoca mechanics are familiar. DNA’s payment processing already gives it a real-time view of merchant card turnover, and that data feeds the lending decision instead of a merchant filling out a separate bank application.

Note what the release calls this, though. The agreement expands an existing funding proposition by adding term lending. So DNA already offered merchant funding. What is new is the loan format, not the category.

Meanwhile the release leans on iwoca’s SME Expert Index for urgency. Some 78% of the finance brokers surveyed expect supply chain disruption to hurt small business performance. Those numbers do double duty. They explain why merchants might need working capital, and why a lender wants to be first in line before a merchant looks elsewhere or decides not to borrow at all.

Fintechbits analysis

Why the DNA Payments iwoca playbook looks familiar

Here the comparison is closer than the release suggests. In August 2025 iwoca ran the identical deal with Teya, another UK payments provider serving small businesses. Same Flexi-Loan product, same £1,000 to £1 million range, same in-app and web portal application, same SME Expert Index framing.

Before that came Countingup in 2024 and Berg Money in 2022, both embedded in platforms sitting close to small-business cash flow. iwoca reaches around 1.8 million businesses across the UK and Germany through this model.

So the DNA Payments iwoca deal does not hand merchants a new lending product. They are gaining a faster on-ramp to one already reachable through a dozen platforms, including a direct competitor of DNA’s.

What the DNA Payments iwoca release does not say

Terms and pricing. The Teya announcement specified repayment from one day to 60 months. This one gives a loan range and a decision speed, and nothing about rates, term length or total cost.

That omission matters more than usual here. Embedded finance built on transaction data is a proven model, and Block’s Square Loans shows it scales. However the convenience argument works precisely because it removes the moment where a borrower would normally compare cost of capital against alternatives.

For DNA Payments, embedded lending makes the merchant relationship stickier and likely carries referral or revenue-share economics on top of processing fees. Neither of those is bad in itself. Still, it is worth naming the incentive.

What to watch next for DNA Payments iwoca lending

The DNA Payments iwoca release leans on an economic backdrop that cuts both ways. If brokers genuinely believe supply chains and energy costs are squeezing small businesses, that is also a reasonable moment to ask whether more short-term debt helps a stressed merchant or simply helps a lender’s growth numbers.

Embedded lending pitched during a nervous stretch can read as support or as opportunism, and often it is some of both. So watch uptake and repayment performance across DNA’s merchant base over the next few quarters. That will say more than any survey statistic in this announcement.

Fintechbits covers embedded lending, SME finance, and payments partnerships. Nothing here constitutes financial or investment advice. All analysis represents the editorial views of Fintechbits.